Anti-Platelet Drugs
Anti-Platelet Drugs is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Mild Head Injury, Antiplatelets, and Anticoagulants
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)
Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.
Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina.
Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina.
Clinical Trials (6)
Mild Head Injury, Antiplatelets, and Anticoagulants
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)
Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.
Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina.
Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina.
Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6